Discovery raises possibility of new medication for Alzheimer’s, Parkinson’s
August 09, 2021
OHSU study reveals that synthetic compound regulates gene implicated in neurodegenerative diseases.
Author: Erik Robinson
Brain surgery education, training ‘radically’ advances in U.S.
August 06, 2021
Report describes cohesive nationwide standards, including boot camp initiated at OHSU.
Scientists discover inherited neurodegenerative disease in monkeys
August 05, 2021
A newly published discovery at OHSU could lead to the development of new therapies to treat Pelizaeus-Merzbacher disease and is the latest in a trove of discoveries made possible by a massive genomic database established at OHSU’s Oregon National Primate Research Center.
OHSU is part of national institute to advance artificial intelligence in aging
August 04, 2021
OHSU is one of five universities nationwide to form a new National Science Foundation-funded institute to design and build intelligent systems to help people age in place.
Ease access to opioid addiction medication, new research suggests
July 28, 2021
OHSU evidence review encourages the use of primary care clinics to improve access to methadone treatment for opioid use disorder
Study links vaccine immune response to age
July 21, 2021
New OHSU laboratory research highlights importance of increasing vaccination to protect older vaccinated adults.
OHSU among 25 centers treating debilitating movement disorder
July 01, 2021
New consensus statement highlights value of early diagnosis and treatment for deadly neurodegenerative disease.
OHSU installs state-of-the-art scanner
June 24, 2021
PET/MRI scanner will be used for clinical care and research.
Two mass vaccination sites tally more than 800,000 doses
June 23, 2021
Two of three major sites close over the weekend as vaccination efforts shift.
Media availability on last day of OHSU mass vaccination site at Portland airport
June 17, 2021
OHSU, Port of Portland, American Red Cross representatives will be available for interviews on site.
